Loading...
Motilal Oswal Recommends Laurus Labs: Stock Poised for 30% Surge After 227% Return in 3 Years
LIVE TV
LOCAL
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Motilal Oswal Recommends Laurus Labs: 30% Upside Potential, 227% Return in 3 Years
C
CNBC Awaaz
•
20-03-2026, 14:00
Motilal Oswal Recommends Laurus Labs: 30% Upside Potential, 227% Return in 3 Years
•
Motilal Oswal reiterates 'Buy' rating for Laurus Labs with a target of ₹1,280, indicating over 30% upside.
•
Growth driven by strong CDMO segment, new contracts for patented products, and advanced technical capabilities.
•
Company expanding into biologics, animal health, crop science, and new markets in Europe and Asia-Pacific.
•
Stable Antiretroviral (ARV) business provides robust earnings base with increasing demand.
•
Laurus Labs shares jumped over 4% on Friday; 63% return in last 12 months.
Read Full Article on Cnbc in Hindi
✦
More like this
✦
More like this
Laurus Labs shares jump 4% on Motilal Oswal 'buy' call, 30% upside seen
C
CNBC TV18
Laurus Labs Shares Soar 100% in 12 Months, Motilal Oswal Predicts Further Upside
C
CNBC TV18
Sumeet Industries: From ₹0.24 to ₹30 in 3 Years, 6,600% Return! New Acquisition Boosts Growth
C
CNBC Awaaz
Laurus Labs Shares Soar 4% on Motilal Oswal's 'Buy' Rating, 30% Upside Predicted
N
News18
Happiest Minds Shares Soar 30% on Raised FY27 Growth Projections, AI Strategy Fuels Momentum
C
CNBC TV18
Shriram Finance Shares Plunge 7%, Biggest Drop in Two Years Amid Regulatory Fears
C
CNBC TV18
